Direct-acting oral anticoagulants in antiphospholipid syndrome
Antiphospholipid syndrome is an acquired autoimmune thrombophilia characterized by the development of recurrent vascular thrombosis of any caliber and type or obstetric pathology and the mandatory identification of persistently positive antiphospholipid antibodies. The main drug in the treatment of...
Saved in:
Main Authors: | T. M. Reshetnyak, K. S. Nurbaeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2021-01-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/2972 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NEW ORAL ANTICOAGULANTS IN THE THERAPY OF ANTIPHOSPHOLIPID SYNDROME
by: M. A. Satybaldyeva, et al.
Published: (2016-07-01) -
Global Antiphospholipid Syndrome Score (GAPSS) in patients with primary antiphospholipid syndrome
by: F. A. Cheldieva, et al.
Published: (2023-02-01) -
Thromboembolic complications in antiphospholipid syndrome and ankylosing spondylitis (two clinical cases)
by: K. S. Nurbaeva, et al.
Published: (2021-02-01) -
Efficacy and safety of long-term use of low molecular weight heparins in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2023-10-01) -
Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-11-01)